Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03972137 · ClinicalTrials.gov registry record · Phase 2
Heart Rate Variability Biofeedback for Smoking Cessation
A Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT03972137: Completed Phase 2 study, sponsored by Rutgers, The State University of New Jersey.
NCT03972137 is a Phase 2 study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 10 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03972137, a Phase 2 study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
Open trial of heart rate variability biofeedback as an adjunct to individualized smoking cessation counseling (SCT) plus transdermal nicotine replacement patch (NRT) in smokers with elevated emotional distress.
Primary Outcome
Number of intervention sessions attended out of 10 possible sessions.
Interventions
- DRUG Transdermal Nicotine patch
- BEHAVIORAL Cognitive-Behavioral Smoking Cessation
- BEHAVIORAL Heart Rate Variability Biofeedback (HRVB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2019-04-24 |
| Est. Completion | 2020-02-20 |
| Phase | Phase 2 |
What the finished NCT03972137 record still lists
NCT03972137 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (92% lower).
The record links to 0 conditions, and to 3 interventions - of which Transdermal Nicotine patch is the first listed.
NCT03972137 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03972137 about?
NCT03972137 is a clinical study titled "Heart Rate Variability Biofeedback for Smoking Cessation". Open trial of heart rate variability biofeedback as an adjunct to individualized smoking cessation counseling (SCT) plus transdermal nicotine replacement patch (NRT) in smokers with elevated emotional distress.
What is the current status of trial NCT03972137?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2019-04-24. Estimated completion is 2020-02-20.
What interventions are being tested in trial NCT03972137?
The interventions under investigation include: Transdermal Nicotine patch (DRUG), Cognitive-Behavioral Smoking Cessation (BEHAVIORAL), Heart Rate Variability Biofeedback (HRVB) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03972137?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03972137's enrollment target sits among peer trials
10 1968th of 2000 higher than 12 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI